The project's primary purpose is to test the hypothesis that oral administration of a low single dose of β-antagonist propranolol (40 mg) reduces pain sensitivity in patients with masticatory muscle pain.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
16
One single dose of Propranolol tablet of 40 mg randomized in one of the two sessions
One single dose of placebo
Section of Clinical Oral Physiology,Department of Dentistry,HEALTH. Aarhus University
Aarhus, Denmark
RECRUITINGSection of Clinical Oral Physiology, Aarhus University
Aarhus C, Denmark
RECRUITINGPain intensity
Numeric Rating Scale 0-10
Time frame: Participants will be asked to score their actual pain level in both of the two experimental sessions they will participate in; an expected average of two weeks between the two sessions
Haemodynamic parameters
Monitoring of pulse and blodpressurevariability, respiration, baroreceptor sensitivity, measured non-invasively by Task Force Monitor.
Time frame: Participants will be monitored during the entire session in both of the two experimental sessions they will participate in; an expected average of two weeks between the two sessions
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.